Interview with Dejan Sencanski, Country Manager Serbia / Montenegro / Albania /…
As the 7th largest pharma MNC worldwide, AstraZeneca is a company that needs no introduction. However, our readers…
Address: Augusta Cesara 12, 11000 Beograd, Republic of Serbia
Tel: 381 11 3336901
Web: http://www.astrazeneca.com/About-Us/Worldwide-locations/Country/Serbia-and-Montenegro
We are active in over 100 countries with a growing presence in emerging markets including China, Brazil, Mexico and Russia.
We employ over 61,000 people (46% in Europe, 24% in the North America, 7% in Latin America and 24% in Asia, Africa and Australasia).
We invest over $4 billion in R&D each year. Around 15,7001 people work in our R&D organisation and we have 14 major R&D centres in eight countries, including Sweden, the US and the UK.
We have 9,300 employees at 23 supply and manufacturing sites in 16 countries.
In 2010, our worldwide sales totalled over $33 billion (including 10 medicines with sales of over $1 billion each).
Alongside our commitment to competitiveness and performance, we continue to be led by our core values to deliver business success responsibly. We are positioned in the top 8% in the sector in the Dow Jones World and STOXX (European) Sustainability Indexes.
We focus our skills and resources on six important areas of healthcare, which include some of the world’s most serious illnesses:
– Cardiovascular
– Gastrointestinal
– Infection
– Neuroscience
– Oncology
– Respiratory
As the 7th largest pharma MNC worldwide, AstraZeneca is a company that needs no introduction. However, our readers…
In a market environment that, up until recently, has been severely difficult for producers of chemical…
Between 2010 and 2012 just one of the 139 new medicines to receive market authorisations globally was approved for…
Nebojsa Skuljec has held various positions in MSD Healthcare across the Balkans before his promotion to country…
Branislav Kotlarik, Ferring’s general manager for the Balkans – whose remit includes Hungary, Romania and…
Gordana Zdravkovic has overseen the progression of BIOTEC International, Serbia through thick and thin. With over…
By reorganizing their management structure, diversifying their offering and presenting an altogether cleaner image,…
Dragan Odzaklijevic, CEO of acb, the exclusive correspondent of leading global insurance broker Aon in Serbia,…
Nenad Djordjevic, managing director of Esensa, introduces the Belgrade company’s 200-strong portfolio of medical…
Ana Grujovic, executive director of the Swiss-Serbian Chamber of Commerce (SSCC) who has been overseeing…
Ana Popovic, general manager of Serbia’s generics association, Genezis, gives her thoughts on how the generics…
Suzana Djordjevic, director of the Hemofarm Foundation in Serbia, explores the themes of collectivism, social care…
Ljubiša Mitof-Višurski, general manager for AbbVie Adria, discusses the main challenges, opportunities and…